Stay updated on Semaglutide Dapagliflozin Combo in One Tablet Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Dapagliflozin Combo in One Tablet Clinical Trial page.

Latest updates to the Semaglutide Dapagliflozin Combo in One Tablet Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision label in the page footer updated from v3.5.3 to v3.5.4, indicating a newer release of the page without changing its substantive content.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe page’s footer “Revision” value is updated from v3.5.2 to v3.5.3, indicating a software/interface version change rather than an update to the study record content.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.1%

- Check86 days agoChange DetectedRevision v3.4.3 was added and revision v3.4.2 was removed from the record history.SummaryDifference0.1%

- Check114 days agoChange DetectedA new revision entry (v3.4.2) was added to the Record History, and two notices were removed (a government funding lapse notice and the v3.4.1 revision note). These are housekeeping changes that do not alter study data or the trial's details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

Stay in the know with updates to Semaglutide Dapagliflozin Combo in One Tablet Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Dapagliflozin Combo in One Tablet Clinical Trial page.